Cargando…
Immunotherapy in the treatment of lymphoma
Relapsed or refractory non-Hodgkin’s lymphomas, especially diffuse large B-cell lymphoma as well as relapsed or refractory Hodgkin lymphomas are hard-to-treat diseases. Patients who do not respond to initial therapy or experience relapse are treated with salvage regimens, and if eligible for aggress...
Autores principales: | Popovic, Lazar S, Matovina-Brko, Gorana, Popovic, Maja, Popovic, Milica, Cvetanovic, Ana, Nikolic, Ivan, Kukic, Biljana, Petrovic, Dragana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246244/ https://www.ncbi.nlm.nih.gov/pubmed/34249225 http://dx.doi.org/10.4252/wjsc.v13.i6.503 |
Ejemplares similares
-
Checkpoint inhibitors in the treatment of urological malignancies
por: Popovic, Lazar S, et al.
Publicado: (2017) -
Targeting triple-negative breast cancer: A clinical perspective
por: POPOVIC, LAZAR S., et al.
Publicado: (2023) -
Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma
por: Popovic, Maja, et al.
Publicado: (2022) -
Paratesticular rhabdomyosarcoma of a young adult
por: Matovina-Brko, Gorana, et al.
Publicado: (2015) -
Effects of Dietary α-Linolenic Acid Treatment and the Efficiency of Its Conversion to Eicosapentaenoic and Docosahexaenoic Acids in Obesity and Related Diseases
por: Takic, Marija, et al.
Publicado: (2022)